These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6434169)

  • 21. [Canthaxanthin retinopathy].
    Nijman NM; Oosterhuis JA; van Bijsterveld OP; Baart de la Faille H; Suurmond D
    Klin Monbl Augenheilkd; 1989 Jan; 194(1):48-51. PubMed ID: 2496261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Static perimetry in canthaxanthin maculopathy.
    Harnois C; Cortin P; Samson J; Boudreault G; Malenfant M; Rousseau A
    Arch Ophthalmol; 1988 Jan; 106(1):58-60. PubMed ID: 3122712
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Retinal thesaurismosis caused by canthaxanthin].
    Metge P; Mandirac-Bonnefoy C; Bellaube P
    Bull Mem Soc Fr Ophtalmol; 1983; 95():547-9. PubMed ID: 6428493
    [No Abstract]   [Full Text] [Related]  

  • 24. Canthaxanthine-induced retinal pigment epithelial changes in the cat.
    Scallon LJ; Burke JM; Mieler WF; Kies JC; Aaberg TM
    Curr Eye Res; 1988 Jul; 7(7):687-93. PubMed ID: 3138067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ultrahigh-resolution optical coherence tomography of canthaxanthine retinal crystals.
    Chan A; Ko TH; Duker JS
    Ophthalmic Surg Lasers Imaging; 2006; 37(2):138-9. PubMed ID: 16583635
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Canthaxanthine (orobronze) retinopathy.
    McGuinness R; Beaumont P
    Aust N Z J Ophthalmol; 1986 Aug; 14(3):239-41. PubMed ID: 3094561
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Maculopathy with golden paillettes].
    Audouy D; Bord G; Audouy R
    Bull Soc Ophtalmol Fr; 1987 Jan; 87(1):191-3. PubMed ID: 3111735
    [No Abstract]   [Full Text] [Related]  

  • 28. [Canthaxanthin retinopathy. Follow-up of over 6 years].
    Weber U; Goerz G; Baseler H; Michaelis L
    Klin Monbl Augenheilkd; 1992 Sep; 201(3):174-7. PubMed ID: 1405396
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A new case of gold-dust maculopathy].
    Franco JL; Adenis JP; Mathon C; Lebraud P
    Bull Soc Ophtalmol Fr; 1985 Oct; 85(10):1035-7. PubMed ID: 3939418
    [No Abstract]   [Full Text] [Related]  

  • 30. The Extent of Retinal Involvement of Canthaxanthin Crystalline Retinopathy Demonstrated by Multimodal Imaging.
    Iyer PG; Shen M; Trivizki O; Barikian A; Chaudhry A; Rosenfeld PJ; Yehoshua Z
    Ophthalmic Surg Lasers Imaging Retina; 2020 Dec; 51(12):727-731. PubMed ID: 33339055
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Canthaxanthine retinopathy.
    Espaillat A; Aiello LP; Arrigg PG; Villalobos R; Silver PM; Cavicchi RW
    Arch Ophthalmol; 1999 Mar; 117(3):412-3. PubMed ID: 10088829
    [No Abstract]   [Full Text] [Related]  

  • 32. beta-Carotene in the treatment of erythropoietic protoporphyria. A short review.
    Krook G; Haeger-Aronsen B
    Acta Derm Venereol Suppl (Stockh); 1982; 100():125-9. PubMed ID: 6819749
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Canthaxanthin retinopathy. An investigation by light and electron microscopy and physicochemical analysis.
    Daicker B; Schiedt K; Adnet JJ; Bermond P
    Graefes Arch Clin Exp Ophthalmol; 1987; 225(3):189-97. PubMed ID: 3111944
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Canthaxanthin retinopathy: long-term observations.
    Hueber A; Rosentreter A; Severin M
    Ophthalmic Res; 2011; 46(2):103-6. PubMed ID: 21346389
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of the benzo(a)pyrene photocarcinogenic effect by beta-carotene and canthaxanthine. Preliminary study.
    Santamaria L; Bianchi A; Arnaboldi A; Andreoni L
    Boll Chim Farm; 1980 Dec; 119(12):745-8. PubMed ID: 6261777
    [No Abstract]   [Full Text] [Related]  

  • 36. [Carotinoid deposits in the retina].
    Philipp W
    Klin Monbl Augenheilkd; 1985 Nov; 187(5):439-40. PubMed ID: 3936971
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Retinal poisoning by Orobronze. Apropos of a case].
    Woillez JP; Hochart G; Drumare I; Ryckewaert M
    Bull Soc Ophtalmol Fr; 1988; 88(8-9):1067-8. PubMed ID: 3150695
    [No Abstract]   [Full Text] [Related]  

  • 38. Aplastic anemia associated with canthaxanthin ingested for 'tanning' purposes.
    Bluhm R; Branch R; Johnston P; Stein R
    JAMA; 1990 Sep; 264(9):1141-2. PubMed ID: 2117075
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Retinal diseases].
    Larricart P
    Bull Soc Ophtalmol Fr; 1985 Nov; Spec No():193-211. PubMed ID: 2866041
    [No Abstract]   [Full Text] [Related]  

  • 40. Canthaxanthine retinopathy.
    Bloomenstein MR; Pinkert RB
    J Am Optom Assoc; 1996 Nov; 67(11):690-2. PubMed ID: 8979663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.